scispace - formally typeset
G

Glenn Barnes

Researcher at Millennium Pharmaceuticals

Publications -  6
Citations -  6239

Glenn Barnes is an academic researcher from Millennium Pharmaceuticals. The author has contributed to research in topics: Insulin resistance & Gene. The author has an hindex of 5, co-authored 6 publications receiving 5939 citations.

Papers
More filters
Journal ArticleDOI

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

TL;DR: It is proposed that obesity-related insulin resistance is, at least in part, a chronic inflammatory disease initiated in adipose tissue, and that macrophage-related inflammatory activities may contribute to the pathogenesis of obesity-induced insulin resistance.
Patent

Methods and compositions for use of inflammatory proteins in the diagnosis and treatment of metabolic disorders

TL;DR: In this article, the authors present methods and compositions for the diagnosis and treatment of metabolic disorders including, but not limited to, obesity, diabetes, and overweight insulin resistance, and also provide methods for identifying a compound capable of modulating a metabolic activity.
Patent

Compositions and methods for the diagnosis and treatment of neuropsychiatric disorders, including schizophrenia

TL;DR: In this article, a method and compositions for diagnosing and treating neuropsychiatric disorders, such as schizophrenia, schizoaffective disorder, bipolar affective disorder, unipolar affective disorders and adolescent conduct disorder, are presented.
Patent

Detection of polymorphisms in the human 5-lipoxygenase gene

TL;DR: In this article, the discovery of polymorphisms within the 5-lipoxygenase gene which are included in a haplotype is described, and a method for identifying specific alleles of polymorphic regions of a 5-LO gene, which can be used to determine whether a patient has a more or less severe phenotype of an inflammatory disease or disorder such as asthma.